An update on the Pharmacovigilance Programme of India

An update on the Pharmacovigilance Programme of India

Bibliographic Details
Main Authors:	Ratan J Lihite, Mangala eLahkar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-09-01
Series:	Frontiers in Pharmacology
Subjects:	Pharmacovigilance ADR AMC Reports PVPi
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00194/full

Similar Items

A study on adverse drug reactions in a tertiary care hospital of Northeast India
by: Ratan J. Lihite, et al.
Published: (2017-06-01)

Pharmacovigilance programme of India
by: Kalaiselvan Vivekanandan, et al.
Published: (2012-01-01)

Prospects of consumer-initiated adverse drug reaction reporting in cardiovascular pharmacovigilance
by: Vinu Wilson, et al.
Published: (2015-01-01)

Studi pharmacovigilance obat di puskesmas X Yogyakarta
by: Mustika Muthaharah, et al.
Published: (2017-06-01)

Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan
by: Akash Syed, et al.
Published: (2018-03-01)

Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report
by: Shrestha S, et al.
Published: (2020-01-01)

An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria
by: Kanayo P. Osemene, et al.
Published: (2017-07-01)

Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting
by: Mala Kharkar, et al.
Published: (2012-01-01)

A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey
by: Anuj Kumar Pathak, et al.
Published: (2016-08-01)

PHASE BEHAVIOR IN POLY ETHYLENE CO-VINYL ALCOHOL BLENDS WITH SOLVATING POLYMERS
by: Keskin, Sevgul
Published: (2006)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01)

Pharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements
by: Karen Maigetter, et al.
Published: (2015-05-01)

Pharmacovigilance system in Saudi Arabia
by: Thamir M. Alshammari, et al.
Published: (2017-03-01)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020-06-01)

An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources
by: Hyunah Shin, et al.
Published: (2021-05-01)

Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis
by: Yogendra Keche, et al.
Published: (2021-01-01)

Pharmacovigilance in India
by: Sarita Mulkalwar, et al.
Published: (2013-01-01)

Knowledge and attitude of health-care professionals toward adverse drug reactions reporting at King Saud Medical City
by: Khaja Moinuddin, et al.
Published: (2018-01-01)

Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur
by: Sachin Hiware, et al.
Published: (2013-01-01)

Knowledge, attitudes and practices of adverse drug reaction reporting among nurses in a tertiary hospital in South West Nigeria
by: Osho, Folasade Monisola
Published: (2019)

Pharmacovigilance Programme of India
by: Duvvuru Ashok Kumar, et al.
Published: (2015-01-01)

Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa
by: M.C. Joubert, et al.
Published: (2016-12-01)

Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa
by: M.C. Joubert, et al.
Published: (2016-10-01)

The attitudes of pharmacists and physicians in Bosnia and Herzegovina towards adverse drug reaction reporting
by: Tarik Catic, et al.
Published: (2016-04-01)

Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU
by: G. N. Gildeeva, et al.
Published: (2019-07-01)

Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01)

In Situ Electrospinning Iodine-Based Fibrous Meshes for Antibacterial Wound Dressing
by: Guo-Sai Liu, et al.
Published: (2018-10-01)

Evaluation of impact of educational modules in improving the adverse drug reaction reporting from MBBS students
by: Sachidananda Adiga MN, et al.
Published: (2016-01-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
by: Vijit Agrawal, et al.
Published: (2019-01-01)

Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
by: Abimbola O. Opadeyi, et al.
Published: (2018-05-01)

A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India
by: Bikash Ranjan Meher, et al.
Published: (2015-01-01)

A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses’ Perspective
by: Rabia Hussain, et al.
Published: (2020-04-01)

A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan
by: Rabia Hussain, et al.
Published: (2018-07-01)

An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India
by: Manali Mangesh Mahajan, et al.
Published: (2018-01-01)

Classiﬁcation of existing problems in the Russian pharmacovigilance system
by: B. K. Romanov, et al.
Published: (2018-09-01)

Adverse drug reactions attributed to fondaparinux and unfractionated heparin in cardiovascular care unit: An observational prospective pilot study in a tertiary care hospital
by: Sahithi Sharma, et al.
Published: (2018-01-01)

Pharmacovigilance in Israel – tools, processes, and actions
by: Eyal Schwartzberg, et al.
Published: (2017-08-01)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
by: Ballari Brahmachari, et al.
Published: (2011-01-01)

Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China
by: Huan Fang, et al.
Published: (2017-06-01)